Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Bando

Showing results (181-190 of 201) with videos related to

Pageof 21
Sort By:
ESMO Real World Data and Digital Oncology|February 6, 2026
Cancer registry as external control data for regulatory submission in JapanH Bando, N Okita, Y Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The emerging role of real-world data in oncology care in JapanH Bando, E Tajima, Y Aoyagi, et al.
Physical Review Letters|November 13, 2008
Isotopic fingerprint of electron-phonon coupling in high-Tc cupratesH Iwasawa, J F Douglas, K Sato, et al.
Cytotherapy|November 13, 2019
Tumorigenicity assessment of cell therapy products: The need for global consensus and points to considerY Sato, H Bando, M Di Piazza, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
The British Journal of Surgery|March 13, 2020
Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212)S Tsukamoto, S Fujita, M Ota, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancerK Yamamoto, I Nakayama, N Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experienceU Okazaki, I Nakayama, N Sakamoto, et al.
Pageof 21

Showing results (181-190 of 201) with videos related to

Sort By:
Pageof 21
ESMO Real World Data and Digital Oncology|February 6, 2026
Cancer registry as external control data for regulatory submission in JapanH Bando, N Okita, Y Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
ARCAD-Asia initiative: leveraging yesterday's data for tomorrowY Takeda, T Misumi, H Bando, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
The emerging role of real-world data in oncology care in JapanH Bando, E Tajima, Y Aoyagi, et al.
Physical Review Letters|November 13, 2008
Isotopic fingerprint of electron-phonon coupling in high-Tc cupratesH Iwasawa, J F Douglas, K Sato, et al.
Cytotherapy|November 13, 2019
Tumorigenicity assessment of cell therapy products: The need for global consensus and points to considerY Sato, H Bando, M Di Piazza, et al.
ESMO Gastrointestinal Oncology|May 28, 2026
A phase II study of pembrolizumab plus chemotherapy with short-course radiotherapy as induction treatment for unresectable locally advanced esophageal squamous cell carcinoma: PALADIN trialD Okemoto, D Kotani, M Nakamura, et al.
ESMO Open|May 27, 2026
Effect of prior anti-EGFR therapy and baseline ctDNA profiling on the efficacy of pertuzumab plus trastuzumab in HER2-amplified metastatic colorectal cancer: an integrated analysis of TRIUMPH/MyPathwayY Matsubara, M Wakabayashi, W Okamoto, et al.
The British Journal of Surgery|March 13, 2020
Long-term follow-up of the randomized trial of mesorectal excision with or without lateral lymph node dissection in rectal cancer (JCOG0212)S Tsukamoto, S Fujita, M Ota, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Temporal dynamics of CLDN18.2 expression following zolbetuximab treatment in advanced gastric cancerK Yamamoto, I Nakayama, N Sakamoto, et al.
ESMO Gastrointestinal Oncology|February 6, 2026
Clinical implementation of simultaneous multiple biomarkers testing for metastatic or recurrent gastroesophageal adenocarcinoma: a single-institutional experienceU Okazaki, I Nakayama, N Sakamoto, et al.
Pageof 21